2020 Grade: F
| 2015 | 2016 | 2017 | 2018-2019 | 2020 |
|---|---|---|---|---|
| NA | NA | F | F | F |
2019-2020 Improvements and Recommendations
Hoosier State lawmakers made no progress in helping Indiana patients secure safe or legal access to cannabis in 2020. ASA encourages Indiana state legislators to organize functional reforms to help patients, including expanding the list of qualifying conditions required for eligibility to participate in the state’s CBD program, removing arbitrary caps on THC content in cannabis-related medications and organizing a fully functional medical cannabis production and sale system for patients to access.
Background
In 2017, Governor Holcomb enacted legislation (HB 1148) that allowed patients suffering from treatment resistant epilepsy to enroll in the state’s medical cannabis program with approval from their neurologist. The Indiana program limits patients to cannabidiol preparations with 0.3 percent or less THC. In 2018 Governor Holcomb signed SEA 52 into law, which authorized the production of CBD from in-state industrial hemp cultivators.
Patient Feedback
Surveyed patients report frustration again this year that medical cannabis, except for very limited amounts of CBD products, are illegal in Indiana.
Share this page
